[Differential therapeutic principles in the drug therapy of high blood pressure].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000037:antagonists & inhibitors / Q000627:therapeutic use; D001581:Benzothiadiazines; D001794:Blood Pressure / Q000187:drug effects; D002306:Cardiac Volume / Q000187:drug effects; D003000:Clonidine / Q000627:therapeutic use; D004232:Diuretics; D004338:Drug Combinations; D006145:Guanethidine / Q000627:therapeutic use; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy*; D007676:Kidney Failure, Chronic / Q000188:drug therapy; D008750:Methyldopa / Q000627:therapeutic use; D012083:Renin / Q000097:blood; D012110:Reserpine / Q000627:therapeutic use; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use; D013148:Spironolactone / Q000627:therapeutic use; D013997:Time Factors; D014223:Triamterene / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D001581:Benzothiadiazines; D004232:Diuretics; D004338:Drug Combinations; D049993:Sodium Chloride Symporter Inhibitors; D006830:Hydralazine; D013148:Spironolactone; D008750:Methyldopa; D012110:Reserpine; D012083:Renin; D003000:Clonidine; D014223:Triamterene; D006145:Guanethidine
Differentialtherapeutische Prinzipien bei der medikamentösen Hochdruckterapie